Your browser doesn't support javascript.
loading
Synthetic Sialosides Terminated with 8-N-Substituted Sialic Acid as Selective Substrates for Sialidases from Bacteria and Influenza Viruses.
Mishra, Bijoyananda; Yuan, Yue; Yu, Hai; Kang, Hyeog; Gao, Jin; Daniels, Robert; Chen, Xi.
Affiliation
  • Mishra B; Department of Chemistry, University of California, One Shields Avenue, Davis, California, 95616, United States.
  • Yuan Y; Department of Chemistry, University of California, One Shields Avenue, Davis, California, 95616, United States.
  • Yu H; Department of Chemistry, University of California, One Shields Avenue, Davis, California, 95616, United States.
  • Kang H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, United States.
  • Gao J; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, United States.
  • Daniels R; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, United States.
  • Chen X; Department of Chemistry, University of California, One Shields Avenue, Davis, California, 95616, United States.
Angew Chem Int Ed Engl ; 63(29): e202403133, 2024 07 15.
Article in En | MEDLINE | ID: mdl-38713874
ABSTRACT
Sialosides containing C8-modified sialic acids are challenging synthetic targets but potentially useful probes for diagnostic substrate profiling of sialidases and elucidating the binding specificity of sialic acid-interacting proteins. Here, we demonstrate efficient chemoenzymatic methods for synthesizing para-nitrophenol-tagged α2-3- and α2-6-linked sialyl galactosides containing C8-acetamido, C8-azido, or C8-amino derivatized N-acetylneuraminic acid (Neu5Ac). High-throughput substrate specificity studies showed that the C8-modification of sialic acid significantly changes its recognition by sialidases from humans, various bacteria, and different influenza A and B viruses. Sialosides carrying Neu5Ac with a C8-azido modification were generally well tolerated by all the sialidases we tested, whereas sialosides containing C8-acetamido-modified Neu5Ac were only cleaved by selective bacterial sialidases. In contrast, sialosides with C8-amino-modified Neu5Ac were cleaved by a combination of selective bacterial and influenza A virus sialidases. These results indicate that sialosides terminated with a C8-amino or C8-acetamido-modified sialic acid can be used with other sialosides for diagnostic profiling of disease-causing sialidase-producing pathogens.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sialic Acids / Neuraminidase Limits: Humans Language: En Journal: Angew Chem Int Ed Engl Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sialic Acids / Neuraminidase Limits: Humans Language: En Journal: Angew Chem Int Ed Engl Year: 2024 Document type: Article Affiliation country: United States